Loading the company…
Loading the company…
Families: Lumbar fusion, Bone graft & orthobiologics.
All companies · Product and company coverage
In the last ten years FDA made 5 decisions for Biogennix (510(k) clearances, De Novo grants, PMA approvals and supplements) under the product codes MedaRep maps to 2 procedure families, the most in 2020 (2). The latest was on 2024-04-30.
| Family | Decisions on record |
|---|---|
| Lumbar fusion | 9 |
| Bone graft & orthobiologics | 7 |
Decisions under the product codes mapped to the procedure families; devices filed under other codes are not here. Applicants are rolled up to Biogennix.